Сравнение на методи
Прегледайте избраните методи един до друг; редовете с разлики са откроени.
| Двойно робастна оценка в изследванията в областта на образованието× | Съгласуване по показател на склонност× | |
|---|---|---|
| Област≠ | Причинно-следствено заключение | Статистика за изследвания |
| Семейство≠ | Regression model | Process / pipeline |
| Година на възникване≠ | 1994-2005 | 1983 |
| Създател≠ | Robins, Rotnitzky & Zhao (1994); Bang & Robins (2005) | Paul Rosenbaum and Donald Rubin |
| Тип≠ | Causal inference / semiparametric estimator | Method |
| Основополагащ източник≠ | Bang, H., & Robins, J. M. (2005). Doubly Robust Estimation in Missing Data and Causal Inference Models. Biometrics, 61(4), 962-973. DOI ↗ | Rosenbaum, P. R., & Rubin, D. B. (1983). The central role of the propensity score in observational studies for causal effects. Biometrika, 70(1), 41–55. DOI ↗ |
| Други названия≠ | DR estimator in education, AIPW in education, augmented IPW in education research, doubly robust causal estimation for educational outcomes | PSM, propensity score weighting, covariate balance |
| Свързани≠ | 6 | 3 |
| Резюме≠ | Doubly robust estimation (DR) is a semiparametric causal inference approach that combines an outcome regression model with a propensity score model. In education research, it is used to estimate the causal effect of educational programs, interventions, or policies on student outcomes when treatment assignment is non-random but observed covariates can account for selection bias. The estimator is consistent if either — not necessarily both — of the two component models is correctly specified. | Propensity score matching (PSM) is a method for reducing confounding bias in observational studies by balancing baseline characteristics between treatment groups, simulating randomization. Developed by Rosenbaum and Rubin (1983), it estimates the probability of receiving treatment given observed covariates, then matches or weights treated and control individuals with similar treatment probabilities. Widely used in medicine, epidemiology, and policy evaluation when randomized trials are infeasible or unethical, enabling estimation of treatment effects while controlling for selection bias. |
| ScholarGateНабор от данни ↗ |
|
|